Consensus development meeting 1995: Combined oral contraceptives and cardiovascular disease. The Consensus Statement issued after the Second European Conference on Sex Steroids and Metabolism, Amsterdam, November 1995

Gynecological Endocrinology

Volumn 10, Issue 1, 1996, Pages 1-5

  Helmerhorst, F M ^a   Bloemenkamp, K W M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; Combined oral contraceptives

Indexed keywords

LIPID; ORAL CONTRACEPTIVE AGENT; LIPOPROTEIN; SEX HORMONE;

BLOOD; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; CARBOHYDRATE METABOLISM; HEMOSTASIS; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; METABOLISM; NETHERLANDS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYMPOSIUM;

CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LIPIDS;

EID: 1542530102     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609041263     Document Type: Conference Paper

References (7)

1. Consensus Development Meeting (1990). Aspects of oral contraceptives of relevance for cardiovascular diseases. Am. J. Obstet. Gynecol., 162, 1335-7
2. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995). Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet, 346, 1575-82
3. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995). Effect of different progestagens in low-oestrogen oral contraceptives on venous thromboembolic disease. Lancet, 346, 1582-8
4. Jick, H., Jick, S. S., Gurewich, V., Myers, M. W. and Vasilakis, C. (1995). Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet, 346, 1589-93
5. Bloemenkamp, K. W. M., Rosendaal, F. R., Helmerhorst, F. M., Buller, H. R. and Vandenbroucke, J. P. (1995). Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing third-generation progestagen. Lancet, 346, 1593-6
6. Spitzer, W. O., Lewis, M. A., Heinemann, L. A., Thorogood, M. and MacRae, K. D. (1996). Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Br. Med. J., 312, 83-8
7. Olsen, C. M. (1995). Consensus Statements. Applying structure. J. Am. Med. Assoc., 273, 72-3